North American Pharmaceutical/Biotech Industry Expects Robust Capital Construction Activity in First Half of 2020, an Industrial Info Market Brief

The Pharmaceutical & Biotech Industry outlook remains strong for the first half of 2020. Industrial Info's Pharma/Bio group is tracking nearly 360 major capital construction projects with a total investment value (TIV) of $14.4 billion set for kickoff in this time frame. The U.S. northeast region leads in expenditures, followed by the southeast and New England regions.